Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 201–300 of 1,000
Opitz, B., Vinzing, M., van Laak, V., Schmeck, B., Heine, G., Günther, S., Preissner, R., Slevogt, H., N′Guessan, P. D., Eitel, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604638200 · Cited by 136
Liu, J., HuangFu, W.-C., Kumar, K. G. S., Qian, J., Casey, J. P., Hamanaka, R. B., Grigoriadou, C., Aldabe, R., Diehl, J. A., & Fuchs, S. Y. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2008.11.008 · Cited by 135
Regulation of the expression and processing of caspase-12
Kalai, M., Lamkanfi, M., Denecker, G., Boogmans, M., Lippens, S., Meeus, A., Declercq, W., & Vandenabeele, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303157 · Cited by 138
“IFN- and - are mainly involved in the response to viral infection (Katze et al., 2002; Taniguchi and Takaoka, 2002).”
BackgroundLipid Droplet, a Key Player in Host-Parasite Interactions
Vallochi, A. L., Teixeira, L., Oliveira, K. D. S., Maya‐Monteiro, C. M., & Bozza, P. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01022 · Cited by 144
“They have their antimicrobial effects by a considerable remodeling transcriptional expression profile of target cells bearing the IFN receptors (188, 189).”
BackgroundAlain, T., Lun, X., Martineau, Y., Sean, P., Pulendran, B., Petroulakis, E., Zemp, F. J., Lemay, C. G., Roy, D., Bell, J. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912344107 · Cited by 132
“Oncogenic transformation is associated with a deficient type I IFN response, which constitutes the first line of defense against virus infection (14, 15).”
BackgroundOxidative stress in viral hepatitis and AIDS
Stehbens, W. E. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2004.04.007 · Cited by 142
Herdy, B., Jaramillo, M., Svitkin, Y. V., Rosenfeld, A. B., Kobayashi, M., Walsh, D., Alain, T., Sean, P., Robichaud, N., Topisirovic, I., et al. (2012) · Nature Immunology · doi:10.1038/ni.2291 · Cited by 127
Glycoprotein of Nonpathogenic Rabies Viruses Is a Key Determinant of Human Cell Apoptosis
Prehaud, C. J. N., Lay, S., Dietzschold, B., & Lafon, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10537-10547.2003 · Cited by 130
“Many viruses have developed strategies to manipulate the survival or the death of the cells that they infect (27).”
BackgroundAnnamalai, T., Saif, L. J., Lu, Z., & Jung, K. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.09.006 · Cited by 148
Molecular basis for PKR activation by PACT or dsRNA
Li, S., Peters, G. A., Ding, K., Zhang, X., Qin, J., & Sen, G. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602317103 · Cited by 130
Gill, M. A., Palucka, K., Barton, T., Ghaffar, F., Jafri, H. S., Banchereau, J., & Ramilo, O. (2005) · The Journal of Infectious Diseases · doi:10.1086/428589 · Cited by 129
Ohno, S., Ono, N., Takeda, M., Takeuchi, K., & Yanagi, Y. (2004) · Journal of General Virology · doi:10.1099/vir.0.80308-0 · Cited by 148
“To replicate efficiently in their hosts, many viruses have evolved strategies to overcome the host’s antiviral defence mechanisms (Goodbourn et al., 2000; Gotoh et al., 2002; Katze et al., 2002).”
BackgroundLevy, D. E., Marié, I., & Prakash, A. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00011-0 · Cited by 142
New insights into internal ribosome entry site elements relevant for viral gene expression
Martínez-Salas, E., Pacheco, A., Serrano, P., & Fernández, N. (2008) · Journal of General Virology · doi:10.1099/vir.0.83426-0 · Cited by 133
“To counteract this response, RNA viruses have evolved distinct strategies (Katze et al., 2002).”
CARD games between virus and host get a new player
Johnson, C., & Gale, M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.11.004 · Cited by 128
Self-citationChen, Z., Rijnbrand, R. C. A., Jangra, R. K., Devaraj, S. G., Qu, L., Ma, Y., Lemon, S. M., & Li, K. (2007) · Virology · doi:10.1016/j.virol.2007.04.023 · Cited by 129
Diversity of Biological Effects Induced by Longwave UVA Rays (UVA1) in Reconstructed Skin
Marionnet, C., Pierrard, C., Golebiewski, C., & Bernerd, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105263 · Cited by 124
“Although elicitation of IFN response is fully documented, down-regulation of IFN signaling has mostly been described in the case of virus for evading host immune response [81].”
Otsuka, M., Kato, N., Moriyama, M., Taniguchi, H., Wang, Y., Dharel, N., Kawabe, T., & Omata, M. (2005) · Hepatology · doi:10.1002/hep.20666 · Cited by 129
Saira, K., Zhou, Y., & Jones, C. (2007) · Journal of Virology · doi:10.1128/jvi.02064-06 · Cited by 137
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells
Ong, H. T., Timm, M., Greipp, P. R., Witzig, T. E., Dispenzieri, A. A., Russell, S. J., & Peng, K.-W. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.002 · Cited by 129
Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
Mehraj, V., & Routy, J.-P. (2015) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s26862 · Cited by 124
Prostaglandin E2 As a Modulator of Viral Infections
Sander, W. J., O’Neill, H. G., & Pohl, C. H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00089 · Cited by 129
“Viruses have also acquired various mechanisms to circumvent these actions of the innate immunity (Cerwenka and Lanier, 2001; Katze et al., 2002).”
BackgroundCekaite, L., Furset, G., Hovig, E. J., & Sioud, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.034 · Cited by 129
Trial Watch: Immunostimulatory cytokines
Vacchelli, E., Galluzzi, L., Eggermont, A., Galon, J., Tartour, E., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.20459 · Cited by 119
“Interferons (IFNs) have first been characterized for their ability to “interfere” with viral replication, and indeed one of their major functions is the establishment of a robust antiviral state in response to infection.(81) In addition, IFNs activate immune cells and facilitate the recognition of tumor cells by the i…”
BackgroundFleming, S. (2016) · Vaccines · doi:10.3390/vaccines4030023 · Cited by 119
“Like the type 1 IFNs, type 3 IFNs are induced through sensing of viral infection through pattern recognition receptors [14,15].”
BackgroundFine-Tuning of Type I Interferon Response by STAT3
Tsai, M.-H., Pai, L., & Lee, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01448 · Cited by 130
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Saha, R. P., Sharma, A. R., Singh, M. K., Samanta, S., Bhakta, S., Mandal, S., Bhattacharya, M., Lee, S. S., & Chakraborty, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01258 · Cited by 123
Taylor, R. T., & Bresnahan, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3873-3877.2005 · Cited by 133
“These newly synthesized IFNs are secreted from the host cell and act in an autocrine and paracrine fashion to activate a global antiviral response within the infected cell and the surrounding tissue (20).”
BackgroundAdams, O., Besken, K., Oberdörfer, C., MacKenzie, C. R., Takikawa, O., & Däubener, W. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2632-2636.2004 · Cited by 119
“Studies conducted using animal models of HSV-1 infections and animal and human cells have shown that control of the primary infection and reactivation depends on the host immune system (1, 14, 34), where the production of interferons (IFNs) plays a key role (23).”
MethodZhang, Q., Guo, X.-K., Gao, L., Huang, C., Li, N., Jia, X., Liu, W., & Feng, W.-H. (2014) · Virology · doi:10.1016/j.virol.2013.12.020 · Cited by 121
“Type I interferons can initiate the activation of JAK/STAT signaling to induce hundreds of IFN-stimulated genes (ISGs), which play an important role in antiviral activities (Katze et al., 2002).”
BackgroundTransport of Sequence-Specific RNA Interference Information Between Cells
Jose, A. M., & Hunter, C. P. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130216 · Cited by 139
“Although several mammalian viruses express proteins that can inhibit RNAi in insect cells (69), some of these same proteins also inhibit the interferon response during viral infection of mammalian cells (53).”
BackgroundCytokine and Chemokine Networks: Pathways to Antiviral Defense
Salazar‐Mather, T. P., & Hokeness, K. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-33397-5_2 · Cited by 128
“These cytokines are potent activators of antiviral pathways [12, 36 , 46, 84, 50] as well as mediators of multiple immunomodulatory functions, including induction of MHC class I expression, activation of NK cell cytotoxicity, and modulation of cytokines and cytokine receptors, including regulation of other type 1 inte…”
BackgroundBonjardim, C. A. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.02.001 · Cited by 137
Molecular constraints to interspecies transmission of viral pathogens
Webby, R. J., Hoffmann, E., & Webster, R. G. (2004) · Nature Medicine · doi:10.1038/nm1151 · Cited by 124
“The ability of a virus to replicate successfully in a given host therefore requires the virus to overcome this potent antiviral response.”
BackgroundLuker, G. D., Prior, J. L., Song, J., Pica, C. M., & Leib, D. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11082-11093.2003 · Cited by 118
“of host interferons and viral regulators of the interferon response to infection have been well characterized (18, 20), defects in adaptive cellular immunity have been associated more closely with severe herpes simplex virus infection and disseminated disease in humans (16, 42, 43).”
BackgroundMeasles Virus V Protein Inhibits NLRP3 Inflammasome-Mediated Interleukin-1β Secretion
Komune, N., Ichinohe, T., Ito, M., & Yanagi, Y. (2011) · Journal of Virology · doi:10.1128/jvi.05942-11 · Cited by 131
“Viruses usually possess strategies to counteract the IFN response (14, 25, 48).”
BackgroundConzelmann, K.-K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5241-5248.2005 · Cited by 116
Ye, J., Chen, Z., Li, Y., Zhao, Z., He, W., Zohaib, A., Song, Y., Deng, C., Zhang, B., Chen, H., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00039-17 · Cited by 140
Diamond, D. L., Jacobs, J. M., Paeper, B., Proll, S. C., Gritsenko, M. A., Carithers, R. L., Larson, A. M., Yeh, M. M., Camp, D. G., Smith, R. D., et al. (2007) · Hepatology · doi:10.1002/hep.21751 · Cited by 114
Self-citationAdvanced biomaterials for cancer immunotherapy
Yang, F., Shi, K. Y., Jia, Y., Hao, Y., Peng, J., & Qian, Z. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0372-z · Cited by 126
RNA interference and innate immunity
Sioud, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.006 · Cited by 117
Wong, M.-T., & Chen, S. S.-L. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.127 · Cited by 133
“64, 65 Type II IFN contains only one member, IFN-c.”
BackgroundInterferon-γ Production by Neutrophils during Bacterial Pneumonia in Mice
Yamada, M., Gomez, J. C., Chugh, P., Lowell, C. A., Dinauer, M. C., Dittmer, D. P., & Doerschuk, C. M. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0592oc · Cited by 123
Gould, D. J. (2011) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2011.03.010 · Cited by 113
“Interferons Interferons (IFNs) are cytokines released by host cells in response to viral infection and are known to have wide-ranging antiviral activity.(49) Interferons are classed into two broad groups: • Type I includes interferon alpha, beta and omega (IFN-α, IFN-β, of IFN-ω) and can be produced by most cell types…”
Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus
Ramaswamy, M., Shi, L., Monick, M. M., Hunninghake, G. W., & Look, D. C. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0410oc · Cited by 113
“The capacity to inhibit IFN effects in host cells has coevolved in several pathogens, and is currently an area of intense research ( 12 , 37).”
BackgroundInfluentialEngineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
Blechacz, B. R. A., Splinter, P. L., Greiner, S. M., Myers, R. M., Peng, K.-W., Federspiel, M. J., Russell, S. J., & LaRusso, N. F. (2006) · Hepatology · doi:10.1002/hep.21437 · Cited by 113
Hepatitis delta virus inhibits alpha interferon signaling #
Pugnale, P., Pazienza, V., Guilloux, K., & Negro, F. (2008) · Hepatology · doi:10.1002/hep.22654 · Cited by 126
Tanabe, Y., Sakamoto, N., Enomoto, N., Kurosaki, M., Ueda, E., Maekawa, S., Yamashiro, T., Nakagawa, M., Chen, C., Kanazawa, N., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/382595 · Cited by 128
Innate Immune Response to Influenza A Virus in Differentiated Human Alveolar Type II Cells
Wang, J., Nikrad, M. P., Phang, T., Gao, B., Alford, T., Ito, Y., Edeen, K. E., Travanty, E. A., Kośmider, B., Hartshorn, K. L., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0108oc · Cited by 113
Wang, X., Liao, Y., Yap, P. L., Png, K. J., Tam, J. P., & Liu, D. X. (2009) · Journal of Virology · doi:10.1128/jvi.01546-09 · Cited by 112
Geiss, G. K., Carter, V. S., He, Y., Kwieciszewski, B., Holzman, T., Korth, M. J., Lázaro, C. A., Fausto, N., Bumgarner, R. E., & Katze, M. G. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6367-6375.2003 · Cited by 112
“Many viruses have evolved strategies to evade the antiviral effects of the IFN response (18, 22, 26 ).”
BackgroundSelf-citationVirus-induced secondary bacterial infection: a concise review
Hendaus, M., Jomha, F., & Alhammadi, A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s87789 · Cited by 110
“Moreover, the respiratory virus-infected epithelia facilitates the attraction of inflammatory cells, including natural killer cells, neutrophils, macrophages, and eosinophils from the bloodstream into the infected site.(32) Finally, the airway epithelium consists of”
Dicer is involved in protection against influenza A virus infection
Matskevich, A. A., & Moelling, K. (2007) · Journal of General Virology · doi:10.1099/vir.0.83103-0 · Cited by 116
“…degradation of viral RNA by the RNAi pathway (Wang & Metzlaff, 2005), it was thought that mammalian viruses might not need to interfere with the RNAi pathway because of the ubiquity and effectiveness of the IFN system, which exerts inhibitory effects on viral gene expression (Katze et al., 2002).”
BackgroundBioluminescence imaging of vaccinia virus: Effects of interferon on viral replication and spread
Luker, K. E., Hutchens, M. A., Schultz, T. L., Pekosz, A. S., & Luker, G. D. (2005) · Virology · doi:10.1016/j.virol.2005.06.049 · Cited by 115
Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist
Ye, Y., Hauns, K., Langland, J., Jacobs, B. L., & Hogue, B. G. (2006) · Journal of Virology · doi:10.1128/jvi.01634-06 · Cited by 123
Suppression of interferon-α signaling by hepatitis E virus
Dong, C., Zafrullah, M., Mixson-Hayden, T. R., Dai, X., Liang, J., Meng, J., & Kamili, S. (2011) · Hepatology · doi:10.1002/hep.25530 · Cited by 119
“It is believed that most, if not all, viruses have the ability to attenuate the IFN response during infection to ensure that the virus has sufficient time to successfully replicate, be packaged in, and released from host cells.(24) Previous studies have reported that hepatitis A, B, C, and D viruses use various strate…”
BackgroundKohanbash, G., & Okada, H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.010 · Cited by 126
“STAT1 and 2 respond to interferons (IFNs), thereby promote IFN-stimulated genes and anti-viral immunity [6, 7].”
BackgroundCovid-19 induced superimposed bacterial infection
Hendaus, M. A., & Jomha, F. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772110 · Cited by 123
“The respiratory virus-infected epithelia also enables the attraction of inflammatory cells, including macrophages, neutrophils, natural killer cells, and eosinophils from the blood circulation into the infected area (Katze et al., 2002).”
BackgroundAllen, C., Vongpunsawad, S., Nakamura, T., James, C. D., Schroeder, M. A., Cattaneo, R., Giannini, C., Krempski, J. W., Peng, K.-W., Goble, J. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1200 · Cited by 119
Jones, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01008 · Cited by 147
“Following IFN-α or IFN-β stimulation, STAT1 forms a heterodimer with STAT2 and this heterodimer binds an ISRE element and activates transcription (133) .”
BackgroundPlasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses
Deal, E. M., Lahl, K., Narváez, C. F., Butcher, E. C., & Greenberg, H. B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60945 · Cited by 106
“affects viral replication while simultaneously activating diverse immune effector cells (10).”
STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells
Liu, Y., Lv, J., Liu, J., Liang, X., Jin, X., Xie, J., Zhang, L., Chen, D., Fiskesund, R., Tang, K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96329 · Cited by 110
Leon‐Icaza, S. A., Zeng, M., & Rosas-Taraco, A. G. (2019) · ExRNA · doi:10.1186/s41544-018-0004-7 · Cited by 103
“Type I interferons are also targets of miRNAs [24], which may result in loss of the antiviral state (for example, miR-466i acts on IFNα, and let-7b acts on IFNβ) [25].”
BackgroundAdams, O., Besken, K., Oberdörfer, C., MacKenzie, C. R., Rüßing, D., & Däubener, W. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.007 · Cited by 105
The role of differential expression of human interferon-A genes in antiviral immunity
Génin, P., Vaccaro, A., & Civas, A. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.07.005 · Cited by 122
“components of virus-induced signaling and IFN-A/B gene expression [23–26].”
BackgroundGene Expression Associated With Interferon Alfa Antiviral Activity in An Hcv Replicon Cell Line
Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S., Run, Q.-G., McIndoe, R., Crawford, J. M., Nelson, D. R., She, J., & Liu, C. (2003) · Hepatology · doi:10.1053/jhep.2003.50184 · Cited by 111
Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins
Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., & Yanagi, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00108-08 · Cited by 117
“Much evidence has indicated that many viruses encode specific proteins to inhibit IFN induction or the Jak/Stat signaling pathway (21, 25, 33).”
BackgroundAntiviral activities of ISG20 in positive-strand RNA virus infections
Zhou, Z., Wang, N., Woodson, S. E., Dong, Q., Wang, J., Liang, Y., Rijnbrand, R. C. A., Wei, L., Nichols, J. E., Guo, J., et al. (2010) · Virology · doi:10.1016/j.virol.2010.10.008 · Cited by 107
Toth, A. M., Zhang, P., Das, S., George, C. X., & Samuel, C. E. (2006) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(06)81010-x · Cited by 112
Bilgin, D. D., Liu, Y., Schiff, M., & Dinesh‐Kumar, S. P. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00125-4 · Cited by 116
3-Deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice
Bray, M., Raymond, J. L., Geisbert, T. W., & Baker, R. O. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00018-9 · Cited by 103
Gottwein, J. M., & Bukh, J. (2008) · Advances in virus research · doi:10.1016/s0065-3527(08)00002-x · Cited by 122
Lambert, S., Langley, D. R., Garnett, J. A., Angell, R. M., Hedgethorne, K., Meanwell, N. A., & Matthews, S. (2014) · Protein Science · doi:10.1002/pro.2456 · Cited by 100
Espert, L., Degols, G., Lin, Y., Vincent, T., Benkirane, M., & Mechti, N. (2005) · Journal of General Virology · doi:10.1099/vir.0.81074-0 · Cited by 111
“, 1993), have been principally implicated in the IFN-induced antiviral response against HIV-1 (for reviews, see Espert et al., 2003b; Katze et al., 2002).”
BackgroundControl of HIV-1 infection by soluble factors of the immune response
DeVico, A. L., & Gallo, R. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro878 · Cited by 115
Varani, S., Cederarv, M., Feld, S., Tammik, C., Frascaroli, G., Landini, M. P., & Söderberg‐Nauclér, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7767 · Cited by 116
“By producing type I IFN, these cells possess a dual role in antiviral responses by directly inhibiting viral replication and by determining the initiation and orchestration of downstream B and T cell responses (11, 13, 14, 31).”
BackgroundThe ORF45 Protein of Kaposi's Sarcoma-Associated Herpesvirus Is Associated with Purified Virions
Zhu, F. X., & Yuan, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4221-4230.2003 · Cited by 106
Kazemi, S., Papadopoulou, S., Li, S., Su, Q., Wang, S., Yoshimura, A., Matlashewski, G., Dever, T. E., & Koromilas, A. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3415-3429.2004 · Cited by 99
“Regulation of protein synthesis by eIF2 phosphorylation plays an important role in the cell’s defense against viral infection (12, 34, 35).”
BackgroundLi, F., Chen, Y., Zhang, Z., Ouyang, J., Wang, Y., Yan, R., Huang, S., Gao, G. F., Guo, G., & Chen, J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1078 · Cited by 111
“For example, various viruses including influenza virus have evolved multiple strategies to circumvent the activation of antiviral protein PKR (7,8).”
BackgroundCrystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain
Potter, J. A., Randall, R. E., & Taylor, G. L. (2008) · BMC Structural Biology · doi:10.1186/1472-6807-8-11 · Cited by 111
Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L
Langland, J., & Jacobs, B. L. (2004) · Virology · doi:10.1016/j.virol.2004.03.012 · Cited by 99
Clemens, M. J. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003766628124 · Cited by 120
“198).”
Grouper Mx confers resistance to nodavirus and interacts with coat protein
Chen, Y.-M., Su, Y.-L., Shie, P.-S., Huang, S.-L., Yang, H., & Chen, T.-Y. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.12.003 · Cited by 95
Ghosh, T. K., Mickelson, D. J., Solberg, J. C., Lipson, K. E., Inglefield, J. R., & Alkan, Ş. Ş. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.04.006 · Cited by 106
Berghäll, H., Sirén, J., Sarkar, D., Julkunen, I., Fisher, P. B., Vainionpää, R., & Matikainen, S. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.04.005 · Cited by 106
STAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α
Sarkis, P. T. N., Ying, S., Xu, R., & Yu, X.-F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4530 · Cited by 103
Lubyová, B., Kellum, M. J., Frisancho, J. A., & Pitha, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309485200 · Cited by 102
The silent treatment: RNAi as a defense against virus infection in mammals
van Rij, R. P., & Andino, R. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.02.006 · Cited by 99
Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency
Jones, C., Geiser, V., Henderson, G., Jiang, Y., Meyer, F., Pérez, S., & Zhang, Y. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.11.009 · Cited by 95
Interferon-β Induction Through Toll-Like Receptor 3 Depends on Double-Stranded RNA Structure
Okahira, S., Nishikawa, F., Nishikawa, S., Akazawa, T., Seya, T., & Matsumoto, M. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.614 · Cited by 111
“:3) g/ml) for 6 h. Luciferase activities are shown as mean relative stimulation plus SD. Representative data from one of three separate experiments are shown. innate immunity (Muller et al ., 1994; Katze et al ., 2002).”
Katsoulidis, E., Mavrommatis, E., Woodard, J., Shields, M. A., Sassano, A., Carayol, N., Sawicki, K. T., Munshi, H. G., & Platanias, L. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151076 · Cited by 90
Zanoni, I., Spreafico, R., Bodio, C., Di Gioia, M., Cigni, C., Broggi, A., Gorletta, T., Caccia, M., Chirico, G., Sironi, L., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.021 · Cited by 90
Baltzis, D., Qu, L., Papadopoulou, S., Blais, J. D., Bell, J. C., Sonenberg, N., & Koromilas, A. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12747-12761.2004 · Cited by 106
“Although many viruses have evolved unique mechanisms to overcome PKR activation (20), it appears that some of these mechanisms also aim at inactivating PERK.”
BackgroundRomieu-Mourez, R., Solis, M., Nardin, A., Goubau, D., Baron-Bodo, V., Lin, R., Massie, B., Salcedo, M., & Hiscott, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1279 · Cited by 89
“Both type I IFNs and IFN-g are produced during the early innate immune response (6).”
Inhibition of the Type I Interferon Antiviral Response During Arenavirus Infection
Borrow, P., Martínez‐Sobrido, L., & de la Torre, J. C. (2010) · Viruses · doi:10.3390/v2112443 · Cited by 94
“Examples include ISG15 (a ubiquitin homologue), ribonuclease L (RNase L), protein kinase R (PKR) [65,66], the 2’,5’-oligoadenylate synthetases (2–5OAS) [67], Mx1 and other GTPases [68–71], deaminases such as double-stranded (ds) RNA-specific adenosine deaminase (ADAR1) and apolipoprotein B mRNA editing enzyme, catalyt…”
BackgroundMicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production
Zhu, X., He, Z., Hu, Y., Wen, W., Lin, C., Yu, J., Pan, J., Li, R., Deng, H., Liao, S., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003088 · Cited by 98
“The host innate immune system acts as the first line of defense against viruses, and establishment of viral infection requires the pathogen to antagonize such innate immunity [4].”
BackgroundIvin, M., Dumigan, A., Vasconcelos, F., Ebner, F., Borroni, M., Kavirayani, A. M., Przybyszewska, K., Ingram, R. J., Lienenklaus, S., Kalinke, U., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006696 · Cited by 90
“By virtue of their inhibition of viral replication type I IFNs became the first cytokines to be used in therapy of human diseases, most notably in infections caused by the hepatitis C virus [58, 59].”
BackgroundNeurological consequences of COVID-19: what have we learned and where do we go from here?
Jarrahi, A., Ahluwalia, M., Khodadadi, H., Salles, É. L., Kolhe, R. B., Hess, D. C., Vale, F. Ĺ., Kumar, M., Baban, B., Vaibhav, K., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01957-4 · Cited by 96
Activation of IL‐27 signalling promotes development of postinfluenza pneumococcal pneumonia
Cao, J., Wang, D., Xu, F., Gong, Y., Wang, H., Song, Z., Li, D., Zhang, H., Li, D., Zhang, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302890 · Cited by 100
“Initial studies have demonstrated that IL-27 contributed to Th1 immunity at the early step of differentiation (Kamiya et al , 2004; Lucas et al , 2003).”
Lippmann, J., Rothenburg, S., Deigendesch, N., Eitel, J., Meixenberger, K., van Laak, V., Slevogt, H., N'Guessan, P. D., Hippenstiel, S., Chakraborty, T., et al. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01232.x · Cited by 87
“Interferon (IFN)-a and -b constitute the type I IFN family, and were originally identified as humoral factors that confer an antiviral state on cells (Katze et al., 2002).”
Background
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.